Concepedia

Anna M. Grawenda

AM

8

Publications

508

Citations

8

H-Index

2012

Active since

Affiliations

University of Oxford(Current)

Ludwig Cancer Research

CRUK/MRC Oxford Institute for Radiation Oncology

Martin Luther University Halle-Wittenberg

Leiden University Medical Center

Anna M. Grawenda is an author at University of Oxford specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2012–2021

8

Publications

8

TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation

Dafni‐Eleftheria Pefani, Daniela Paňková, Aswin Abraham et al. · Molecular Cell · 2016 · 142 citations · Full text

, , +5

RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73

Angelos Papaspyropoulos, Leanne Bradley, Asmita Thapa et al. · Nature Communications · 2018 · 100 citations · Full text

Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion

Nikola Vlahov, Simon Scrace, Manuel Sarmiento Soto et al. · Current Biology · 2015 · 81 citations · Full text

Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer

Kristiaan Lenos, Anna M. Grawenda, Kirsten Lodder et al. · Cancer Research · 2012 · 64 citations · Full text

, , +20

A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma

Karen S. Yee, Lukasz F. Grochola, Garth Hamilton et al. · Cancer Research · 2012 · 46 citations · Full text

, , +14

Rows per page

1–5 of 8